Skip to main content
MEMPHASYS LIMITED. logo

MEMPHASYS LIMITED. — Investor Relations & Filings

Ticker · MEM ISIN · AU000000MEM5 LEI · 549300RZ3LBXHF3WXL97 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2026-05-24 Director's Dealing
Country AU Australia
Listing ASX MEM

About MEMPHASYS LIMITED.

https://www.memphasys.com/

Memphasys Limited is a biotechnology company specializing in the development of advanced cell separation and reproductive biotechnology solutions. The company's core technology platform utilizes proprietary membranes and electrophoresis to isolate high-quality cells from biological fluids. Its flagship product, the Felix™ system, is an automated device designed for the rapid separation of high-quality sperm from semen samples for use in human assisted reproductive technology (ART) procedures. This technology aims to improve clinical outcomes by selecting sperm with lower DNA fragmentation and higher motility compared to traditional centrifuge-based techniques. Beyond human fertility, the company applies its bio-separation expertise to animal health, including diagnostic tools for stallion fertility. Memphasys focuses on providing innovative solutions that enhance efficiency and success rates in the global reproductive health market.

Recent filings

Filing Released Lang Actions
Final Director's Interest Notice 2 pages 404.2KB
Director's Dealing Classification · 90% confidence The document is an ASX Appendix 3Z “Final Director’s Interest Notice” disclosing a director’s shareholdings and cessation date under listing rule 3.19A.3. This is a report of personal share interests by a director, fitting the Director’s Dealing category.
2026-05-24 English
Initial Director's Interest Notice 2 pages 354.5KB
Director's Dealing Classification · 90% confidence The document is an ASX Appendix 3X "Initial Director's Interest Notice" reporting the director’s holdings and interests in shares and options under listing rule 3.19A.1. This is a report of personal share transactions and holdings by a company director (insider dealing), matching the Director’s Dealing category.
2026-05-24 English
Change of Chair 3 pages 417.1KB
Board/Management Information Classification · 90% confidence The document is an ASX release announcing the resignation of the Non-Executive Chair and the appointment of a new Non-Executive Chairman. It details a board-level change in leadership, with biographies and effective dates. This fits the definition of a Board/Management Information announcement (MANG).
2026-05-18 English
Updated Securities Trading Policy 14 pages 542.2KB
Governance Information Classification · 95% confidence The document is an ASX release from Memphasys Limited dated 4 May 2026. It primarily contains the company's updated Securities Trading Policy, which details rules and procedures regarding insider trading, closed periods, approval processes for trading company securities, and other governance-related matters. The content is a policy document rather than a financial report, earnings release, or announcement of voting results. It does not contain financial statements, earnings data, or management discussion of financial results. It also is not a brief announcement or a report publication notice. The document is focused on internal governance and compliance rules related to securities trading by directors and employees. Therefore, the most appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed policy content support this classification with high confidence.
2026-05-03 English
Quarterly Activities/Appendix 4C Cash Flow Report 14 pages 1.3MB
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' for the period ended 31 March 2026, issued by Memphasys Limited. It contains detailed financial highlights, operational updates, management commentary, and references to an 'Appendix 4C cashflow report'. It provides substantive financial and operational analysis rather than just an announcement of a report. Therefore, it is classified as an Interim/Quarterly Report. Q3 2026
2026-04-16 English
Investor Presentation - April 2026 20 pages 1.8MB
Investor Presentation Classification · 95% confidence The document is an ASX release dated 7 April 2026 from Memphasys Limited announcing an upcoming investor webinar and the release of an updated investor presentation. The text includes detailed information about the company's technology, commercial progress, regulatory approvals, market strategy, and financial highlights such as revenue disclosures and sales performance. The document explicitly states that the updated investor presentation is attached and will be used in investor meetings and webinars. The content is focused on providing a comprehensive update to investors, including financial and strategic information, but it is presented as a presentation material rather than a formal financial report like an annual or interim report. The document is not a transcript of a call, nor is it a regulatory filing, audit report, or other specific filing types. Given the nature of the content and the explicit mention of an investor presentation, the most appropriate classification is Investor Presentation (IP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2026-04-06 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.